Short Interest in Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Expands By 25.6%

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) was the target of a large growth in short interest in April. As of April 15th, there was short interest totaling 363,971 shares, a growth of 25.6% from the March 31st total of 289,781 shares. Based on an average daily trading volume, of 57,468 shares, the short-interest ratio is presently 6.3 days.

Insider Buying and Selling

In other Neonc Technologies news, President Amir F. Heshmatpour bought 10,000 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was purchased at an average cost of $4.52 per share, for a total transaction of $45,200.00. Following the acquisition, the president owned 3,062,000 shares of the company’s stock, valued at $13,840,240. The trade was a 0.33% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last 90 days, insiders have bought 70,700 shares of company stock valued at $381,990.

Institutional Trading of Neonc Technologies

Hedge funds have recently bought and sold shares of the company. HighPoint Advisor Group LLC grew its stake in Neonc Technologies by 424.8% in the 3rd quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after acquiring an additional 769,163 shares during the period. Bank of America Corp DE acquired a new stake in shares of Neonc Technologies during the second quarter worth $801,000. Vanguard Group Inc. acquired a new stake in shares of Neonc Technologies during the third quarter worth $1,279,000. 683 Capital Management LLC purchased a new stake in shares of Neonc Technologies in the fourth quarter valued at $442,000. Finally, Global Retirement Partners LLC purchased a new stake in shares of Neonc Technologies in the third quarter valued at $434,000.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. BTIG Research started coverage on shares of Neonc Technologies in a research report on Friday, April 24th. They issued a “buy” rating and a $15.00 price target on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a research note on Friday, March 27th. Finally, Zacks Research upgraded Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $15.00.

Neonc Technologies Price Performance

NASDAQ:NTHI traded up $0.12 on Thursday, reaching $4.42. The stock had a trading volume of 92,563 shares, compared to its average volume of 55,992. Neonc Technologies has a 12-month low of $3.20 and a 12-month high of $12.99. The firm’s fifty day moving average is $7.20 and its two-hundred day moving average is $8.47.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.